Dag Hjelle • 1959 • Oslo • 12 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
M MEDCIS AS	Managing Director/CEO	468,675	367,443	100 % directly
F FJORD MEDICAL AS	Managing Director/CEO	-	173,217	100 % indirectly
F FOLVENGAARD AQUA AS	Managing Director/CEO	-	-	48 % indirectly
P PURECUT TECHNOLOGIES AS	Managing Director/CEO	280,122	5,359	33.33 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
M MEDCIS AS	Chairman	468,675	367,443	100 % directly
F FJORD MEDICAL AS	Chairman	-	173,217	100 % indirectly
F FOLVENGAARD AS	Chairman	2,634,863	330,357	60 % directly
F FOLVENGAARD AQUA AS	Board Member	-	-	48 % indirectly
P PURECUT TECHNOLOGIES AS	Chairman	280,122	5,359	33.33 % indirectly
B BIOSYNTECH AS	Board Member	-	173,053	20 % indirectly
H HJELLEDALEN KRAFTLAG AS	Chairman	2,143,355	2,906,535	9.52 % directly
D DAG HJELLE	Holder	-	-	-

Last update: Dec 4, 2024

Related industries4

Electricity, gas, steam and air conditioning supply
Professional, scientific and technical activities
Agriculture, forestry and fishing
Manufacturing

Direct relationships5

ØS
Øystein Selen1961
BIOSYNTECH AS
SJ
Stig Jarle Rødseth1955
FOLVENGAARD AQUA AS
RO
Rolf Olav Reitan Gjørven1991
HJELLEDALEN KRAFTLAG AS
TK
Tom Kristian Hoffmann1948
BIOSYNTECH AS
EF
Eli Folven1983
HJELLEDALEN KRAFTLAG AS

Shares owned by Dag Hjelle

Name	Share class	Total operating income	Total equity	Share
M MEDCIS AS	Ordinære aksjer	468,675	367,443	100 % directly
F FJORD MEDICAL AS		0	173,217	100 % indirectly
F FOLVENGAARD AS	Ordinære aksjer	2,634,863	330,357	60 % directly
F FOLVENGAARD AQUA AS		-	-	48 % indirectly
P PURECUT TECHNOLOGIES AS		280,122	5,359	33.33 % indirectly
B BIOSYNTECH AS		0	173,053	20 % indirectly
H HJELLEDALEN KRAFTLAG AS	Ordinære aksjer	2,143,355	2,906,535	9.52 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024